Roy M. Takumi
- Democratic
Primary
Requires drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a sixteen per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame.
No votes to display
Carried over to 2022 Regular Session.
Referred to HHH, CPC, FIN, referral sheet 1
Introduced and Pass First Reading.
Pending introduction.
| Bill Text Versions | Format |
|---|---|
| HB17 | PDF HTML |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Hawaii State Legislature.
If you notice any inconsistencies with these official sources, feel free to file an issue.